McAnaney Adam sold $154K of OSCR
McAnaney Adam (Chief Legal Officer) sold 7,065 shares of Oscar Health, Inc. (OSCR) at $21.74 ($0.15M total) on 2026-06-02 under a Rule 10b5-1 trading plan.
How this was made
The 30-second read
Why it matters
The disclosure updates the insider transaction record for OSCR but does not introduce new fundamentals (no earnings, guidance, deal, or regulatory action mentioned).
Market read
Primarily informational for positioning/ownership tracking; unlikely to drive a directional trade by itself.
What to watch
Traders may check whether multiple insiders are selling/buying around the same window, but this article contains only one specific Form 4 datapoint.
Background
SEC Form 4 reports insider transactions in the issuer’s own stock; Rule 10b5-1 plans are pre-scheduled to mitigate trading on material nonpublic information.
Ticker impact
Oscar Health disclosed an open-market sale by its Chief Legal Officer under a pre-arranged 10b5-1 plan (7,065 shares at $21.74).
Low likelihood of a sustained price move solely from this Form 4; any reaction is likely short-lived.
The transaction is explicitly an open-market sale conducted under a pre-arranged Rule 10b5-1 plan, which typically reduces interpretive signal versus discretionary selling.
Market effects
Minimal; single-company insider sale under 10b5-1 provides no clear read-across to the broader health-insurance/insurtech space.
None.
None.
Counterpoint
Even 10b5-1 sales can coincide with management views on near-term risk, but the filing provides no accompanying rationale or change in guidance.
Key entities
- issuerOscar Health, Inc.
Subject of the Form 4 insider transaction filing.
- insiderMcAnaney Adam
Chief Legal Officer who sold 7,065 OSCR shares under a pre-arranged 10b5-1 plan.
